1. Immunobiology of Newcastle Disease Virus and Its Use for Prophylactic Vaccination in Poultry and as Adjuvant for Therapeutic Vaccination in Cancer Patients
   Volker Schirrmacher, 2017, IJMS CrossRef
2. Fifty Years of Clinical Application of Newcastle Disease Virus: Time to Celebrate!
   Volker Schirrmacher, 2016, Biomedicines CrossRef
3. Potentiating prostate cancer immunotherapy with oncolytic viruses
   Patrick Lee et al, 2018, Nat Rev Urol CrossRef
4. Exploring the role of oncolytic viruses in hepatobiliary cancers
   Pavan Tenneti et al, 2018, Immunotherapy CrossRef
5. Making Oncolytic Virotherapy a Clinical Reality: The European Contribution
   Margaret R. Duffy et al, 2017, Human Gene Therapy CrossRef
6. Remarkable Pathologic Change in Advanced Prostate Cancer Patient Using Dendritic Cell–Cytokine-Induced Killer Combined Therapy: A Case Report
   Peng Xu et al, 2015, Clinical Genitourinary Cancer CrossRef
7. Long-term survival of a breast cancer patient with extensive liver metastases upon immune and virotherapy: a case report
   Volker Schirrmacher et al, 2015, Immunotherapy CrossRef
8. Durchbrechen von Therapieresistenzen
   Volker Schirrmacher, 2015, Wien klin Mag CrossRef
9. Cancer-reactive memory T cells from bone marrow: Spontaneous induction and therapeutic potential (Review)
   VOLKER SCHIRRMACHER, 2015 CrossRef
10. Oncolytic Newcastle disease virus as a prospective anti-cancer therapy. A biologic agent with potential to break therapy resistance
    Volker Schirrmacher, 2015, Expert Opinion on Biological Therapy CrossRef
11. Recurrent scrotal edema in a patient with radiation enteritis: A case report
    SHENGXIAN FAN et al, 2016 CrossRef
12. Breaking Therapy Resistance: An Update on Oncolytic Newcastle Disease Virus for Improvements of Cancer Therapy
    null Schirrmacher et al, 2019, Biomedicines CrossRef
13. Low-frequency ultrasound-induced VEGF suppression and synergy with dendritic cell-mediated anti-tumor immunity in murine prostate cancer cells in vitro
    Wei Zhang et al, 2017, Sci Rep CrossRef
14. Immunotherapy with subcutaneous immunogenic autologous tumor lysate increases murine glioblastoma survival
    Jochen Belmans et al, 2017, Sci Rep CrossRef
15. Evidence-Based Medicine in Oncology: Commercial Versus Patient Benefit
    Volker Schirrmacher et al, 2020, Biomedicines CrossRef
16. Modulated Electrohyperthermia: A New Hope for Cancer Patients
    Huda F. Alshaibi et al, 2020, BioMed Research International CrossRef
17. Randomized Controlled Immunotherapy Clinical Trials for GBM Challenged
    Stefaan W. Van Gool et al, 2020, Cancers CrossRef
18. The Oncolytic Herpes Simplex Virus Talimogene Laherparepvec Shows Promising Efficacy in Neuroendocrine Cancer Cell Lines
    Linus D. Kloker et al, 2019, Neuroendocrinology CrossRef
19. Oncolytic viral vectors in the era of diversified cancer therapy: from preclinical to clinical
    Chao Tang et al, 2022, Clin Transl Oncol CrossRef
20. Tumor Temperature: Friend or Foe of Virus-Based Cancer Immunotherapy
    Jason P. Knapp et al, 2022, Biomedicines CrossRef
21. Treatment of Pelvic and Spinal Bone Metastases: Radiotherapy and Hyperthermia Alone vs. in Combination
    Jong-Hun Kim et al, 2024, Cancers CrossRef